Atlas Trials

Study to Evaluate the Optimal Dose of Remifentanil During MRI of the Heart Under General Anaesthesia

Clinical trial NCT02481791 · UNKNOWN

Trial details

NCT number
NCT02481791
Sponsor
Alder Hey Children's NHS Foundation Trust
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
ChildrenHeart DiseasesAnaesthesiaMagnetic Resonance Imaging
Start date
2015-07-01
Primary completion
2019-12-31
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.